Companies House does not verify the accuracy of the information filed

GSK FINANCE (NO.3) LIMITED

Company number 12615561

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
23 Sep 2024	CH03	Secretary's details changed for Ms Victoria Anne Whyte on 11 September 2024	View PDF Secretary's details changed for Ms Victoria Anne Whyte on 11 September 2024 - link opens in a new window - 1 page (1 page)
03 Jun 2024	AD01	Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS United Kingdom to C/O Bdo Llp 5 Temple Square Temple Street Liverpool L2 5RH on 3 June 2024	View PDF Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS United Kingdom to C/O Bdo Llp 5 Temple Square Temple Street Liverpool L2 5RH on 3 June 2024 - link opens in a new window - 3 pages (3 pages)
03 Jun 2024	LIQ01	Declaration of solvency	View PDF Declaration of solvency - link opens in a new window - 6 pages (6 pages)
03 Jun 2024	600	Appointment of a voluntary liquidator	View PDF Appointment of a voluntary liquidator - link opens in a new window - 3 pages (3 pages)
03 Jun 2024	RESOLUTIONS	Resolutions LRESSP ‐ Special resolution to wind up on 2024-05-21	View PDF Resolutions LRESSP ‐ Special resolution to wind up on 2024-05-21 - link opens in a new window - 1 page (1 page)
26 Mar 2024	SH19	Statement of capital on 26 March 2024 USD 1.25	View PDF Statement of capital on 26 March 2024 USD 1.25 - link opens in a new window - 3 pages (3 pages)
26 Mar 2024	RESOLUTIONS	Resolutions RES13 ‐ Cancel share premium 21/03/2024 RES06 ‐ Resolution of reduction in issued share capital	View PDF Resolutions RES13 ‐ Cancel share premium 21/03/2024 RES06 ‐ Resolution of reduction in issued share capital - link opens in a new window - 1 page (1 page)
26 Mar 2024	CAP-SS	Solvency Statement dated 21/03/24	View PDF Solvency Statement dated 21/03/24 - link opens in a new window - 1 page (1 page)
26 Mar 2024	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 1 page (1 page)
08 Mar 2024	RESOLUTIONS	Resolutions RES02 ‐ Resolution of re-registration	View PDF Resolutions RES02 ‐ Resolution of re-registration - link opens in a new window - 1 page (1 page)
08 Mar 2024	MAR	Re-registration of Memorandum and Articles	View PDF Re-registration of Memorandum and Articles - link opens in a new window - 31 pages (31 pages)
08 Mar 2024	CERT10	Certificate of re-registration from Public Limited Company to Private	View PDF Certificate of re-registration from Public Limited Company to Private - link opens in a new window - 1 page (1 page)
08 Mar 2024	RR02	Re-registration from a public company to a private limited company	View PDF Re-registration from a public company to a private limited company - link opens in a new window - 1 page (1 page)
25 Oct 2023	CS01	Confirmation statement made on 25 October 2023 with no updates	View PDF Confirmation statement made on 25 October 2023 with no updates - link opens in a new window - 3 pages (3 pages)
16 Aug 2023	PSC05	Change of details for Glaxo Group Limited as a person with significant control on 6 June 2023	View PDF Change of details for Glaxo Group Limited as a person with significant control on 6 June 2023 - link opens in a new window - 2 pages (2 pages)
27 Jun 2023	AA	Full accounts made up to 31 December 2022	View PDF Full accounts made up to 31 December 2022 - link opens in a new window - 22 pages (22 pages)
14 Oct 2022	CS01	Confirmation statement made on 14 October 2022 with no updates	View PDF Confirmation statement made on 14 October 2022 with no updates - link opens in a new window - 3 pages (3 pages)
15 Jun 2022	AA	Full accounts made up to 31 December 2021	View PDF Full accounts made up to 31 December 2021 - link opens in a new window - 23 pages (23 pages)
25 May 2022	CS01	Confirmation statement made on 20 May 2022 with no updates	View PDF Confirmation statement made on 20 May 2022 with no updates - link opens in a new window - 3 pages (3 pages)
20 Jul 2021	CS01	Confirmation statement made on 20 May 2021 with updates	View PDF Confirmation statement made on 20 May 2021 with updates - link opens in a new window - 4 pages (4 pages)
04 Jul 2021	AA	Full accounts made up to 31 December 2020	View PDF Full accounts made up to 31 December 2020 - link opens in a new window - 20 pages (20 pages)
16 Nov 2020	TM01	Termination of appointment of Ciara Martha Lynch as a director on 9 November 2020	View PDF Termination of appointment of Ciara Martha Lynch as a director on 9 November 2020 - link opens in a new window - 1 page (1 page)
17 Jul 2020	SH18	Statement of directors in accordance with reduction of capital following redenomination	View PDF Statement of directors in accordance with reduction of capital following redenomination - link opens in a new window - 2 pages (2 pages)
17 Jul 2020	RESOLUTIONS	Resolutions RES18 ‐ Resolution to reduce share capital on re-denomination
17 Jul 2020	SH15	Reduction of capital following redenomination. Statement of capital on 17 July 2020 USD 62,501.25	View PDF Reduction of capital following redenomination. Statement of capital on 17 July 2020 USD 62,501.25 - link opens in a new window - 4 pages (4 pages)

Cookies on Companies House services

GSK FINANCE (NO.3) LIMITED

Filter by category